NeuroTrax Science Team and Glen M. Doniger, PhD
Sleep is often treated as a lifestyle issue, but the evidence tells a more serious story. Sleep quality, sleep duration, and daytime sleepiness all have measurable effects on cognitive performance, particularly attention, processing speed, memory, and executive function.
A newly published University of Miami study using NeuroTrax highlights this point. The MAGNETO study evaluated adults with obstructive sleep apnea (OSA) whose primary respiratory symptoms were effectively managed by adherence to positive airway pressure (PAP) therapy. Still, many participants showed objective residual excessive daytime sleepiness (EDS). Importantly, this sleepiness was associated with poorer performance in global cognition and multiple NeuroTrax cognitive domains, including memory, executive function, attention, and processing speed [1].
Patients with objective EDS performed 0.43 to 0.58 standard deviations worse on NeuroTrax measures compared to those without EDS. This difference is considered clinically meaningful and is roughly equivalent to a 1–2 point shift on brief screening tools like the MoCA or MMSE [1].
Good sleep is not just about feeling rested. It supports the cognitive functions people rely on every day: staying focused, processing information efficiently, retaining information, and making decisions.
The MAGNETO study is particularly relevant because it shows that cognitive risk can persist even when OSA treatment appears successful by respiratory measures. PAP adherence and normal apnea indices did not necessarily translate into restored cognitive performance [1]. This highlights an important gap in care: without objective cognitive assessment, residual impairment may go undetected.
NeuroTrax has been used to quantify how sleep disruption affects cognition in multiple studies.
In adolescents, Cohen-Zion et al. demonstrated that even modest sleep restriction (6 to 6.5 hours per night) resulted in significantly poorer performance in information processing speed, executive function, attention, and motor skills compared to extended sleep conditions (10 to 10.5 hours) [2]. Under optimal sleep conditions, participants were able to maintain performance even as task difficulty increased, a benefit that disappeared under sleep restriction [2].
In a neurological population, Sater et al. showed that sleep efficiency measured via polysomnography was significantly associated with NeuroTrax global cognitive scores, executive function, and information processing in patients with multiple sclerosis [3]. The study additionally found that fragmented sleep, measured as increased wake after sleep onset (WASO), was linked to poorer verbal function performance [3].
Sleep-related cognitive impairment is also evident in demanding professional environments. Flinn et al. reported measurable declines in global cognition, attention, and processing speed in junior doctors following extended work hours and sleep deprivation [4]. These findings demonstrate that even highly trained individuals are vulnerable to the cognitive effects of insufficient sleep [4].
The key clinically is not just to show that sleep affects cognition, but to measure how cognition changes when sleep changes.
NeuroTrax enables detailed tracking across multiple cognitive domains, elucidating whether sleep disruption is affecting attention, processing speed, memory, executive function, or global cognition. This is particularly valuable in longitudinal monitoring of response to PAP therapy, behavioral sleep interventions, or changes in work schedules.
The MAGNETO study suggests that residual EDS may represent a distinct cognitive risk phenotype in treated OSA [1]. Two patients may appear equally well managed from a respiratory perspective, yet differ significantly in cognitive performance. Objective cognitive testing helps reveal that difference.
Sleep health should be considered a core component of cognitive wellness. Consistent sleep duration, reduced fragmentation, and effective management of sleep disorders all play a role in maintaining cognitive function.
The growing body of NeuroTrax sleep research points to a consistent conclusion: sleep disruption leads to measurable cognitive changes. With digital neurometrics like NeuroTrax, these changes can be objectively quantified, tracked, and ultimately addressed for improved daily function and quality of life.
References:
[1] Junco, B., Ramos, A., Hernandez-Cardenache, R., Wallace, D. M., Dib, S., Pérez Negrón, A. P., Vanderkley, A., and McIntosh, R. (2026). Cognition and psychomotor vigilance in treated sleep apnea patients with and without daytime sleepiness: The MAGNETO study. Journal of Clinical Sleep Medicine, 22(1):60. DOI: 10.1007/s44470-026-00077-9
[2] Cohen-Zion, M., Shabi, A., Levy, S., Glasner, L., and Wiener, A. (2016). Effects of partial sleep deprivation on information processing speed in adolescence. Journal of the International Neuropsychological Society, 22(4), 388–398. DOI: 10.1017/S1355617716000072
[3] Sater, R. A., Gudesblatt, M., Kresa-Reahl, K., Brandes, D. W., and Sater, P. A. (2015). The relationship between objective parameters of sleep and measures of fatigue, depression, and cognition in multiple sclerosis. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 1(2055217315577828). DOI: 10.1177/2055217315577828
[4] Flinn, F. and Armstrong, C. (2011). Junior doctors’ extended work hours and the effects on their performance: the Irish case. International Journal for Quality in Health Care, 23(2), 210–217. DOI: 10.1093/intqhc/mzq088
